Charles River Laboratories International Book Value Per Share Growth & History (CRL)
Charles River Laboratories International's book value per share was $64.30 for fiscal 2025.
View full Charles River Laboratories International company overviewCharles River Laboratories International annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-27 | $64.30 | -$3.39 | −5.00% |
| 2024 | 2024-12-28 | $67.69 | -$2.38 | −3.39% |
| 2023 | 2023-12-30 | $70.06 | $11.64 | +19.92% |
| 2022 | 2022-12-31 | $58.42 | $8.21 | +16.35% |
| 2021 | 2021-12-25 | $50.21 | $7.72 | +18.18% |
| 2020 | 2020-12-26 | $42.49 | $9.09 | +27.21% |
| 2019 | 2019-12-28 | $33.40 | $6.08 | +22.24% |
| 2018 | 2018-12-29 | $27.33 | $5.28 | +23.94% |
| 2017 | 2017-12-30 | $22.05 | $4.38 | +24.79% |
| 2016 | 2016-12-31 | $17.67 | $1.97 | +12.54% |
| 2015 | 2015-12-26 | $15.70 | $1.49 | +10.52% |
| 2014 | 2014-12-27 | $14.20 | $0.72 | +5.37% |
| 2013 | 2013-12-28 | $13.48 | $1.19 | +9.65% |
| 2012 | 2012-12-29 | $12.29 | $1.54 | +14.31% |
| 2011 | 2011-12-31 | $10.75 | -$1.43 | −11.71% |
| 2010 | 2010-12-25 | $12.18 | -$8.70 | −41.66% |
| 2009 | 2009-12-26 | $20.88 | — | — |
Charles River Laboratories International quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-27 | $59.50 | -$8.65 | −12.69% |
| Q1 2026 | 2026-03-28 | $61.05 | -$3.99 | −6.13% |
| Q4 2025 | 2025-12-27 | $64.30 | -$3.39 | −5.00% |
| Q3 2025 | 2025-09-27 | $69.20 | -$4.77 | −6.45% |
| Q2 2025 | 2025-06-28 | $68.14 | -$3.98 | −5.52% |
| Q1 2025 | 2025-03-29 | $65.04 | -$5.64 | −7.98% |
| Q4 2024 | 2024-12-28 | $67.69 | -$2.38 | −3.39% |
| Q3 2024 | 2024-09-28 | $73.97 | $9.52 | +14.77% |
| Q2 2024 | 2024-06-29 | $72.13 | $8.70 | +13.72% |
| Q1 2024 | 2024-03-30 | $70.67 | $9.94 | +16.36% |
| Q4 2023 | 2023-12-30 | $70.06 | $11.64 | +19.92% |
| Q3 2023 | 2023-09-30 | $64.45 | $12.82 | +24.83% |
| Q2 2023 | 2023-07-01 | $63.43 | $11.37 | +21.84% |
| Q1 2023 | 2023-04-01 | $60.74 | $9.35 | +18.21% |
| Q4 2022 | 2022-12-31 | $58.42 | $8.21 | +16.35% |
| Q3 2022 | 2022-09-24 | $51.63 | $3.54 | +7.37% |
| Q2 2022 | 2022-06-25 | $52.06 | $6.05 | +13.15% |
| Q1 2022 | 2022-03-26 | $51.38 | $7.89 | +18.14% |
| Q4 2021 | 2021-12-25 | $50.21 | $7.72 | +18.18% |
| Q3 2021 | 2021-09-25 | $48.09 | $9.95 | +26.08% |
| Q2 2021 | 2021-06-26 | $46.01 | $10.72 | +30.36% |
| Q1 2021 | 2021-03-27 | $43.49 | $10.11 | +30.28% |
| Q4 2020 | 2020-12-26 | $42.49 | $9.09 | +27.21% |
| Q3 2020 | 2020-09-26 | $38.14 | $6.76 | +21.56% |
| Q2 2020 | 2020-06-27 | $35.29 | $5.48 | +18.36% |
| Q1 2020 | 2020-03-28 | $33.38 | $4.70 | +16.39% |
| Q4 2019 | 2019-12-28 | $33.40 | $6.08 | +22.24% |
| Q3 2019 | 2019-09-28 | $31.38 | $5.32 | +20.42% |
| Q2 2019 | 2019-06-29 | $29.82 | $5.19 | +21.09% |
| Q1 2019 | 2019-03-30 | $28.68 | $4.89 | +20.54% |
| Q4 2018 | 2018-12-29 | $27.33 | $5.28 | +23.94% |
| Q3 2018 | 2018-09-29 | $26.06 | $4.47 | +20.71% |
| Q2 2018 | 2018-06-30 | $24.62 | $4.38 | +21.61% |
| Q1 2018 | 2018-03-31 | $23.79 | $5.39 | +29.32% |
| Q4 2017 | 2017-12-30 | $22.05 | $4.38 | +24.79% |
| Q3 2017 | 2017-09-30 | $21.59 | $3.24 | +17.69% |
| Q2 2017 | 2017-07-01 | $20.25 | $2.66 | +15.16% |
| Q1 2017 | 2017-04-01 | $18.40 | $1.85 | +11.16% |
| Q4 2016 | 2016-12-31 | $17.67 | $1.97 | +12.54% |
| Q3 2016 | 2016-09-24 | $18.34 | $3.23 | +21.40% |
| Q2 2016 | 2016-06-25 | $17.58 | $2.61 | +17.39% |
| Q1 2016 | 2016-03-26 | $16.55 | $2.54 | +18.10% |
| Q4 2015 | 2015-12-26 | $15.70 | $1.49 | +10.52% |
| Q3 2015 | 2015-09-26 | $15.11 | $0.77 | +5.40% |
| Q2 2015 | 2015-06-27 | $14.98 | $0.65 | +4.56% |
| Q1 2015 | 2015-03-28 | $14.02 | — | — |
| Q4 2014 | 2014-12-27 | $14.20 | $0.72 | +5.37% |
| Q3 2014 | 2014-09-27 | $14.33 | $0.73 | +5.35% |
| Q2 2014 | 2014-06-28 | $14.32 | $1.11 | +8.42% |
| Q4 2013 | 2013-12-28 | $13.48 | $1.19 | +9.65% |
| Q3 2013 | 2013-09-28 | $13.61 | $1.29 | +10.52% |
| Q2 2013 | 2013-06-29 | $13.21 | $1.66 | +14.39% |
| Q1 2013 | 2013-03-30 | $12.81 | $1.54 | +13.63% |
| Q4 2012 | 2012-12-29 | $12.29 | $1.54 | +14.31% |
| Q3 2012 | 2012-09-29 | $12.31 | $1.46 | +13.42% |
| Q2 2012 | 2012-06-30 | $11.55 | $0.10 | +0.87% |
| Q1 2012 | 2012-03-31 | $11.28 | $0.37 | +3.37% |
| Q4 2011 | 2011-12-31 | $10.75 | -$1.43 | −11.71% |
| Q3 2011 | 2011-09-24 | $10.85 | -$7.18 | −39.82% |
| Q2 2011 | 2011-06-25 | $11.45 | -$9.63 | −45.67% |
| Q1 2011 | 2011-03-26 | $10.91 | — | — |
| Q4 2010 | 2010-12-25 | $12.18 | -$8.70 | −41.66% |
| Q3 2010 | 2010-09-25 | $18.04 | — | — |
| Q2 2010 | 2010-06-26 | $21.08 | — | — |
| Q4 2009 | 2009-12-26 | $20.88 | — | — |
Charles River Laboratories International book value per share trends
Over the last five fiscal years, Charles River Laboratories International's book value per share increased from $42.49 to $64.30, a change of $21.81. The latest reported quarter, Q2 2026, shows $59.50.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Charles River Laboratories International source filings ↗